GH earnings: next report 2026-07-30, real EPS beat/miss history, analyst consensus Buy, P/E -44.47. Updated 2026-07-23.
Guardant Health (GH) Research Hub
Guardant Health (GH) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-09-11, shares last closed at 157.38 USD (-3.32%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -44.47, market cap 19.81B. This hub links to the full technical, earnings and options research available for GH.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 157.38 USD (-3.32%) |
| 52-week range | 125 USD – 176.58 USD |
| Trend regime | Range |
| 14-day RSI | 40 (Bearish) |
| Trailing P/E | -44.47 |
| Market cap | 19.81B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-30 |
Available research for GH
Covered Call on GH: how it works, illustrative setup around the real 157.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on GH: how it works, illustrative setup around the real 157.38 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on GH: how it works, illustrative setup around the real 157.38 USD price, max profit/loss, breakeven and when to use it. Educational.
GH technical analysis: range, last 157.38 USD, RSI 40, 52w range 125 USD–176.58 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is GH in?
Guardant Health (GH) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is GH in an uptrend or downtrend?
As of 2026-09-11, GH is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is GH's trailing P/E ratio?
GH's trailing P/E is -44.47, with a market cap of 19.81B. See the earnings research page for full valuation detail.
When does GH next report earnings?
GH is next scheduled to report earnings on 2026-07-30, with a consensus EPS estimate of -0.41 USD.